Rodman David Malcom 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Rodman David Malcom（CIK 1672659）在 1 家公司共报告 96 笔 SEC Form 4 内部人交易（最近一笔 2026-08-12）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-12 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 买入 | 2,170 | $34,720 |
| 2026-08-12 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 卖出 | 2,170 | $58,785 |
| 2026-07-20 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 买入 | 416 | $6,423 |
| 2026-07-20 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 卖出 | 416 | $11,036 |
| 2026-07-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 买入 | 3,542 | $36,128 |
| 2026-07-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 买入 | 4,167 | $59,380 |
| 2026-07-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 买入 | 6,349 | $6,857 |
| 2026-07-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 卖出 | 14,058 | $387,717 |
| 2026-07-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 卖出 | 6,349 | $168,955 |
| 2026-07-10 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 买入 | 2,171 | $34,736 |
| 2026-07-10 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 卖出 | 2,171 | $65,781 |
| 2026-06-17 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 卖出 | 9,890 | $235,481 |
| 2026-06-17 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 买入 | 3,542 | $36,128 |
| 2026-06-17 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 买入 | 4,167 | $59,380 |
| 2026-06-17 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 买入 | 417 | $6,438 |
| 2026-06-17 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 卖出 | 4,584 | $114,600 |
| 2026-06-12 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 买入 | 2,170 | $34,720 |
| 2026-06-12 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 卖出 | 2,170 | $54,250 |
| 2026-06-12 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 买入 | 6,349 | $6,857 |
| 2026-06-12 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 卖出 | 6,349 | $151,932 |
| 2026-05-19 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 买入 | 417 | $6,438 |
| 2026-05-19 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 卖出 | 417 | $11,488 |
| 2026-05-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 买入 | 2,171 | $34,736 |
| 2026-05-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 卖出 | 2,171 | $64,500 |
| 2026-05-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 买入 | 6,348 | $6,856 |
来源：SEC Form 4 申报文件 · 截至 2026-08-12